1-7 of 7
Authors: Ryusuke Hatae
Sort by
Journal Article
Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model Open Access
Ryusuke Hatae and others
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf074, https://doi.org/10.1093/noajnl/vdaf074
Published: 12 April 2025
Journal Article
Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma Open Access
Ryosuke Otsuji and others
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae069, https://doi.org/10.1093/noajnl/vdae069
Published: 08 May 2024
Journal Article
10098-MPC-10 HOW SHOULD WE RESPOND TO REPEATED WHO REVISIONS? IN-HOUSE MOLECULAR DIAGNOSIS SYSTEM BY ADVANCED MEDICAL SYSTEM Open Access
Nobuhiro Hata and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_5, December 2023, Pages v11–v12, https://doi.org/10.1093/noajnl/vdad141.045
Published: 10 December 2023
Journal Article
MPC-06 Cutting-edge of Cancer Genomic Medicine for brain tumors Open Access
Masahiro Mizoguchi and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii12, https://doi.org/10.1093/noajnl/vdaa143.051
Published: 28 November 2020
Journal Article
IM-03 CD206 expression in peripheral blood-derived induced-microglia-like cells as a surrogate biomarker for the specific immune microenvironment of glioma Open Access
Nobuhiro Hata and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii7, https://doi.org/10.1093/noajnl/vdaa143.031
Published: 28 November 2020
Journal Article
ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application Open Access
Yusuke Funakoshi and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Pages ii7–ii8, https://doi.org/10.1093/noajnl/vdaa143.032
Published: 28 November 2020
Journal Article
ACT-16 THE POTENTIAL OF HYPOFRACTIONATED RADIOTHERAPY AND BEVACIZUMAB FOR GLIOBLASTOMA TREATMENT Open Access
Nobuhiro Hata and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii15, https://doi.org/10.1093/noajnl/vdz039.065
Published: 16 December 2019
Advertisement
Advertisement